Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$1.09 -54.11%
Market Cap
$48.4M
Price Target
Refer to Report
Volume
62.7M
52wk Range
$0.79 - $8.32
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.